Latest STAAR Surgical News & Updates

See the latest news and media coverage for STAAR. We track all announcements, press releases, and industry mentions in real time, all in one place.

STAAR Surgical (STAAR)

Implantable lens designer and manufacturer

staar.com

Headquarters: Lake Forest, United States
Founded year: 1982
Company type: Public company
Number of employees: 700–1,000

Last updated Today

Latest news about STAAR Surgical (STAAR)

In short: STAAR Surgical reported a strong Q1 2026 financial recovery, expanded its FDA age indications, and transitioned to a standalone strategy.

Company announcements

May 13 STAAR

STAAR Surgical reports Q1 2026 results

Net sales reached $93.5 million, net income was $5.2 million, and Adjusted EBITDA totaled $24.4 million.

April 8 STAAR

STAAR Surgical reports preliminary Q1 2026 net sales

The company expects net sales in excess of $90 million for Q1, driven by China and Americas, and anticipates improved adjusted EBITDA.

March 3 STAAR

STAAR Surgical reports Q4 and FY 2025 financial results

Net sales grew 18% in Q4 but declined 24% for the full year; net loss narrowed.

February 27 STAAR

STAAR Surgical surpasses 4 million ICLs sold globally

The milestone reflects a shift from laser-based vision correction to lens-based procedures, driven by regulatory and clinical progress.

Media coverage

June 25 The Globe and Mail

Staar Surgical Reports Q4 2025 Results and Outlook

Staar Surgical ( (STAA)) just unveiled an announcement. On March 3, 2026, STAAR Surgical reported fourth quarter 2025 net sales of $57.8 million, up 18.1...

June 16 Kalkine Media

Is STAAR Surgical Regaining Market Momentum?

STAAR Surgical is drawing renewed attention as valuation discussions intensify, with market participants assessing growth ...

June 12 Yahoo Finance

Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders

Let’s dig into the relative performance of STAAR Surgical (NASDAQ:STAA) and its peers as we unravel ...

June 4 Yahoo Finance

How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets

STAAR Surgical’s modeled fair value has been updated from US$21.11 to US$29.67, a shift that puts a brighter spotlight on how analysts are recalibrating their...

Never miss news about STAAR

Track STAAR and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

STAAR competitors & trending companies

Browse news for competitors to STAAR and other trending companies.